{"url":"https://lda.senate.gov/api/v1/filings/af0ef381-5a8a-499b-86d7-e686e221dad6/","filing_uuid":"af0ef381-5a8a-499b-86d7-e686e221dad6","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2022,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/af0ef381-5a8a-499b-86d7-e686e221dad6/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kurt E Imhof","dt_posted":"2022-10-20T23:32:22-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"411 Swedeland Road","registrant_address_2":"Suite 23-1080","registrant_different_address":true,"registrant_city":"King of Prussia","registrant_state":"PA","registrant_zip":"19406","registrant":{"id":401105511,"url":"https://lda.senate.gov/api/v1/registrants/401105511/","house_registrant_id":null,"name":"LIFE SCIENCES PENNSYLVANIA","description":"Trade association","address_1":"411 Swedeland Road","address_2":"Suite 23-1080","address_3":null,"address_4":null,"city":"King of Prussia","state":"PA","state_display":"Pennsylvania","zip":"19406","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LARA FLYNN","contact_telephone":"+1 610-947-6800","dt_updated":"2026-07-13T12:03:34.908122-04:00"},"client":{"id":203773,"url":"https://lda.senate.gov/api/v1/clients/203773/","client_id":12,"name":"LIFE SCIENCES PENNSYLVANIA","general_description":"Trade association","client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Spoke with members of the Pennsylvania Congressional Delegation and hosted discussions with members of Life Sciences Pennsylvania to keep congressional representatives, and their staff, up to date on Pennsylvania's life sciences ecosystem and the community's efforts to research and develop medicines and technologies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72383,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"IMHOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Continued to advocate to PA congressional delegation members for policies, like the PASTEUR Act, that incentivize the research and development of novel AMR medicines and educate members and their staff on the importance of antimicrobial research Expressed support for proposals that limit out-of-pocket costs for patients and expressed concern for certain drug pricing provisions in the Inflation Reduction Act. Continued to ask members of the Pennsylvania delegation to sign on to legislation that would align the breakthrough designation of medical technologies with reimbursement by CMS - an issue important to our medical device and diagnostic members.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72383,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"IMHOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Continued to urge the Pennsylvania Congressional Delegation to support robust NIH funding and discussed ideas, such as locating ARPA-H in Pennsylvania to further invest in basic scientific research.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72383,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"IMHOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Continued to advocate for robust NIH funding and funding for the Biomedical Advance Research and Development Authority (BARDA) and the Strategic National Stockpile (SNS) to support public health and pandemic preparedness efforts. Expressed the critical need to ensure the SBIR/STTR programs are reauthorized prior to their September 30 expiration. Supported efforts to locate ARPA-H in Pennsylvania.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72383,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"IMHOF","suffix":null,"suffix_display":null},"covered_position":"VP, Policy and Public Affairs","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Expressed continued support to members of the Pennsylvania Congressional Delegation on the Orphan Drug Tax Credit (ODTC)- noting how changes to ODTC could disrupt investment in research and development for rare disease medicines.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72383,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"IMHOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Expressed Life Sciences Pennsylvania's support for efficient reauthorization of the prescription drug user fee agreement, medical device user fee agreement and biosimilar user fee agreement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72383,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"IMHOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Supported efforts to maintain the strong intellectual property protections that exist in the United States and the importance of the Bayh-Dole Act in incentivizing the development of novel medicines and technologies. Expressed concerns on TRIPS Waiver provisions undermining IP protections.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72383,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"IMHOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Expressed support to PA congressional delegation for policies, like the HELP Copays Act, that would require health insurance plans to apply certain payments made by beneficiaries toward a plan's cost sharing requirements.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72383,"prefix":null,"prefix_display":null,"first_name":"KURT","nickname":null,"middle_name":null,"last_name":"IMHOF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}